{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:51:33Z","timestamp":1790153493698,"version":"4.0.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC Early Career Fellowship","doi-asserted-by":"publisher","award":["1035149"],"award-info":[{"award-number":["1035149"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC Career Development Fellowship","doi-asserted-by":"publisher","award":["1035383"],"award-info":[{"award-number":["1035383"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC Practitioner Research Fellowship","doi-asserted-by":"publisher","award":["1028432"],"award-info":[{"award-number":["1028432"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC Principal Research Fellowship","doi-asserted-by":"publisher","award":["1041742"],"award-info":[{"award-number":["1041742"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Substance Misuse Prevention and Service Improvements Grant Fund"},{"DOI":"10.13039\/501100000276","name":"Department of Health and Ageing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.drugpo.2015.07.010","type":"journal-article","created":{"date-parts":[[2015,7,26]],"date-time":"2015-07-26T15:02:45Z","timestamp":1437922965000},"page":"950-957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs"],"prefix":"10.1016","volume":"26","author":[{"given":"Sarah","family":"Larney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Dore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.drugpo.2015.07.010_bib0005","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/cid\/cit305","article-title":"Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution Ssetting: ETHOS Study","volume":"57","author":"Alavi","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0010","series-title":"The needle exchange surveillance initiative (NESI): prevalence of HCV and injecting risk behaviours among people who inject drugs attending equipment provision services in Scotland 2008\/2009 & 2010","author":"Allen","year":"2012"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.010_bib0015","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.drugpo.2012.07.006","article-title":"Association between harm reduction intervention uptake and recent hepatitis C infection among people who inject drugs attending sites that provide sterile injecting equipment in Scotland","volume":"23","author":"Allen","year":"2012","journal-title":"The International Journal on Drug Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugpo.2013.08.005","article-title":"Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study","volume":"25","author":"Aspinall","year":"2014","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0025","series-title":"National Drug Strategy Household Survey 2010 - detailed findings","author":"Australian Institute of Health and Welfare","year":"2011"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0030","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1093\/cid\/cit271","article-title":"Models of care for the management of HCV among people who use drugs: one size does not fit all","volume":"57","author":"Bruggmann","year":"2013","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0035","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/add.12834","article-title":"A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia","volume":"110","author":"Burns","year":"2015","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.010_bib0040","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/j.1360-0443.2009.02633.x","article-title":"Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention","volume":"104","author":"Burns","year":"2009","journal-title":"Addiction"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.010_bib0045","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/aje\/kwh306","article-title":"Estimating long-term trends in the incidence and prevalence of opiate use\/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths","volume":"160","author":"De Angelis","year":"2004","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.010_bib0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/0962280208094691","article-title":"An evidence synthesis approach to estimating Hepatitis C prevalence in England and Wales","volume":"18","author":"De Angelis","year":"2009","journal-title":"Statistical Methods in Medical Research"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0055","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.drugalcdep.2013.07.008","article-title":"Risk factors for progression to regular injection drug use among street-involved youth in a Canadian setting","volume":"133","author":"DeBeck","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/dar.12066","article-title":"Estimating the proportion of prescription opioid consumption in Australia that is accounted for by people who inject drugs","author":"Degenhardt","year":"2013","journal-title":"Drug and Alcohol Review"},{"issue":"9810","key":"10.1016\/j.drugpo.2015.07.010_bib0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","article-title":"Extent of illicit drug use and dependence, and their contribution to the global burden of disease","volume":"379","author":"Degenhardt","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0070","series-title":"Estimating the number of current regular heroin users in NSW and Australia 1997\u20132002","author":"Degenhardt","year":"2004"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0075","series-title":"Trends in injecting drug use in Europe","author":"EMCDDA","year":"2010"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0080","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11524-008-9330-7","article-title":"Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a National Repeated Cross-sectional Survey of Needle and Syringe Program Attendees in Australia, 1995\u20132004","volume":"86","author":"Falster","year":"2009","journal-title":"Journal of Urban Health"},{"issue":"9","key":"10.1016\/j.drugpo.2015.07.010_bib0085","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1360-0443.1992.tb02743.x","article-title":"The incidence of illicit drug use in the United States, 1962\u20131989","volume":"87","author":"Gfroerer","year":"1992","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2014.01.002","article-title":"Can hepatitis C virus infection be eradicated in people who inject drugs?","volume":"104","author":"Grebely","year":"2014","journal-title":"Antiviral Research"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.010_bib0095","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/MEG.0b013e32832a8c4c","article-title":"Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support","volume":"22","author":"Grebely","year":"2010","journal-title":"European Journal Gastroenterology Hepatology"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.drugalcdep.2006.09.018","article-title":"Referral for chronic hepatitis C treatment from a drug dependency treatment setting","volume":"88","author":"Hallinan","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/ADM.0b013e3181add3de","article-title":"Successful integration of hepatitis C evaluation and treatment services with methadone maintenance","volume":"4","author":"Harris","year":"2010","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/eurpub\/ckr083","article-title":"Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis","volume":"22","author":"Harris","year":"2012","journal-title":"European Journal of Public Health"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0115","series-title":"Estimating the prevalence of problem drug use in Europe","first-page":"247","article-title":"Cross-validating at local level","author":"Hartnoll","year":"1997"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.010_bib0120","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1177\/0962280208094687","article-title":"Capture-recapture and anchored prevalence estimation of injecting drug users in England: national and regional estimates","volume":"18","author":"Hay","year":"2009","journal-title":"Statistical Methods in Medical Research"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0125","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/add.12185","article-title":"Multiple parameter evidence synthesis\u2014a potential solution for when information on drug use and harm is in conflict","volume":"108","author":"Hickman","year":"2013","journal-title":"Addiction"},{"issue":"9","key":"10.1016\/j.drugpo.2015.07.010_bib0130","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jech.2003.015164","article-title":"Injecting drug use in Brighton, Liverpool, and London: best estimates of prevalence and coverage of public health indicators","volume":"58","author":"Hickman","year":"2004","journal-title":"Journal of Epidemiology and Community Health"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0135","series-title":"Epidemiology of Drug Abuse","first-page":"113","article-title":"Indirect methods to estimate prevalence","author":"Hickman","year":"2005"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0140","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1360-0443.2011.03741.x","article-title":"Commentary on Mehta et al. (2012): natural history of injecting drug use","volume":"107","author":"Hickman","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/oxfordjournals.epirev.a036192","article-title":"Capture-recapture methods in epidemiology: methods and limitations","volume":"17","author":"Hook","year":"1995","journal-title":"Epidemiologic Reviews"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0150","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drugalcdep.2013.03.021","article-title":"The relationship between age and risky injecting behaviours among a sample of Australian people who inject drugs","volume":"132","author":"Horyniak","year":"2013","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0155","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.58.5.503","article-title":"A 33-year follow-up of narcotics addicts","volume":"58","author":"Hser","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.010_bib0160","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/aje\/kwu056","article-title":"Recapture or precapture? Fallibility of standard capture-recapture methods in the presence of referrals between sources","volume":"179","author":"Jones","year":"2014","journal-title":"American Journal of Epidemiology"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0165","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/clinids\/11.2.289","article-title":"Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries","volume":"11","author":"Kaplan","year":"1989","journal-title":"Reviews of Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0170","doi-asserted-by":"crossref","first-page":"c3172","DOI":"10.1136\/bmj.c3172","article-title":"Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment","volume":"341","author":"Kimber","year":"2010","journal-title":"British Medical Journal"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.010_bib0175","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/j.1360-0443.2008.02276.x","article-title":"Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods","volume":"103","author":"Kimber","year":"2008","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.drugpo.2015.07.010_bib0180","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/aje\/kwi263","article-title":"Prior information in behavioral capture-recapture methods: demographic influences on drug injectors\u2019 propensity to be listed in data sources and their drug-related mortality","volume":"162","author":"King","year":"2005","journal-title":"American Journal of Epidemiology"},{"issue":"4","key":"10.1016\/j.drugpo.2015.07.010_bib0185","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1046\/j.1360-0443.2000.95459110.x","article-title":"Methadone maintenance and cessation of injecting drug use: results from the Amsterdam Cohort Study","volume":"95","author":"Langendam","year":"2000","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2014.12.027","article-title":"Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: a 15-year observational cohort study","author":"Larney","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0195","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/hep.26387","article-title":"The incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis","author":"Larney","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.010_bib0200","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1046\/j.1360-0443.2001.9634337.x","article-title":"Back-projection estimates of the number of dependent heroin users in Australia","volume":"96","author":"Law","year":"2001","journal-title":"Addiction"},{"issue":"8","key":"10.1016\/j.drugpo.2015.07.010_bib0205","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/cid\/cis1202","article-title":"Safety and effectiveness of a nurse-led outreach program for assessment and treatment of chronic hepatitis C in the custodial setting","volume":"56","author":"Lloyd","year":"2013","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1016\/j.drugpo.2015.07.010_bib0210","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/add.12643","article-title":"A prospective study of hepatitis C incidence in Australian prisoners","volume":"109","author":"Luciani","year":"2014","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drugpo.2013.07.001","article-title":"Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness","volume":"25","author":"MacArthur","year":"2014","journal-title":"International Journal on Drug Policy"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0220","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jvh.12338","article-title":"HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact","volume":"22","author":"Martin","year":"2015","journal-title":"Journal of Viral Hepatitis"},{"issue":"SUPPL.2","key":"10.1016\/j.drugpo.2015.07.010_bib0230","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0235","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jtbi.2010.12.041","article-title":"Mathematical modelling of hepatitis C treatment for injecting drug users","volume":"274","author":"Martin","year":"2011","journal-title":"Journal of Theoretical Biology"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0245","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002209.pub2","article-title":"Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence","volume":"3","author":"Mattick","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0250","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub3","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2008","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0255","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2011.03602.x","article-title":"Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India","volume":"107","author":"Mehta","year":"2012","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.drugpo.2015.07.010_bib0260","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.drugalcdep.2012.05.036","article-title":"Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK","volume":"126","author":"Mills","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0265","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugalcdep.2014.06.015","article-title":"Errors in reported degrees and respondent driven sampling: Implications for bias","volume":"142","author":"Mills","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1521-0391.2011.00194.x","article-title":"Injection first: a unique group of injection drug users in Tijuana, Mexico","volume":"21","author":"Morris","year":"2012","journal-title":"The American Journal on Addictions"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0275","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: Results of systematic reviews","volume":"378","author":"Nelson","year":"2011","journal-title":"The Lancet"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.010_bib0280","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/add.12682","article-title":"The impact of methadone maintenance therapy on hepatitis C incidence among illicit drug users","volume":"109","author":"Nolan","year":"2014","journal-title":"Addiction"},{"issue":"9525","key":"10.1016\/j.drugpo.2015.07.010_bib0285","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(06)68804-1","article-title":"Incidence of heroin use in Zurich, Switzerland: a treatment case register analysis","volume":"367","author":"Nordt","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0290","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/sim.6047","article-title":"Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland","volume":"33","author":"Overstall","year":"2014","journal-title":"Statistics in Medicine"},{"issue":"5","key":"10.1016\/j.drugpo.2015.07.010_bib0295","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0272989X0102100502","article-title":"Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users","volume":"21","author":"Pollack","year":"2001","journal-title":"Medical Decision Making"},{"issue":"Suppl 2","key":"10.1016\/j.drugpo.2015.07.010_bib0300","doi-asserted-by":"crossref","first-page":"S70","DOI":"10.1093\/cid\/cit265","article-title":"Enhancing assessment and treatment of hepatitis C in the custodial setting","volume":"57","author":"Post","year":"2013","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0305","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/add.12948","article-title":"Estimating the number of people with hepatitis C virus who have ever inject drugs and have yet to be diagnosed: an evidence synthesis approach for Scotland","volume":"110","author":"Prevost","year":"2015","journal-title":"Addiction"},{"issue":"2\u20133","key":"10.1016\/j.drugpo.2015.07.010_bib0310","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2007.05.026","article-title":"Modelling the hepatitis C virus epidemic in Australia","volume":"91","author":"Razali","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2015.07.010_bib0315","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1258\/095646207779949880","article-title":"High hepatitis C virus prevalence and incidence among Canadian intravenous drug users","volume":"18","author":"Roy","year":"2007","journal-title":"International Journal of STD and AIDS"},{"issue":"1-3","key":"10.1016\/j.drugpo.2015.07.010_bib0320","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.drugalcdep.2009.01.006","article-title":"Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience","volume":"102","author":"Roy","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drugalcdep.2005.11.007","article-title":"Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988\u20132000","volume":"83","author":"Shah","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0330","first-page":"305","article-title":"Establishment of a database of diagnosed HCV-infected persons in Scotland","volume":"6","author":"Shaw","year":"2003","journal-title":"Communicable Disease and Public Health"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0335","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0962280208094704","article-title":"Estimating the prevalence of ex-injecting drug use in the population","volume":"18","author":"Sweeting","year":"2009","journal-title":"Statistical Methods in Medical Research"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0340","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.drugalcdep.2005.01.013","article-title":"Prediction of relapse to frequent heroin use and the role of methadone prescription: an analysis of the Amsterdam Cohort Study among drug users","volume":"79","author":"Termorshuizen","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.drugpo.2015.07.010_bib0345","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1001\/jamainternmed.2014.5416","article-title":"Association of opioid agonist therapy with lower incidence of hepatitis C virus infection in young adult injection drug users","volume":"174","author":"Tsui","year":"2014","journal-title":"JAMA Internal Medicine"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.010_bib0350","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1111\/j.1360-0443.2011.03515.x","article-title":"The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence","volume":"106","author":"Turner","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0355","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/archpsyc.1973.04200020065009","article-title":"A 20-year follow-up of New York narcotic addicts","volume":"29","author":"Vaillant","year":"1973","journal-title":"Archives of General Psychiatry"},{"issue":"9","key":"10.1016\/j.drugpo.2015.07.010_bib0360","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1111\/j.1360-0443.2007.01912.x","article-title":"Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users","volume":"102","author":"Van Den Berg","year":"2007","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.drugpo.2015.07.010_bib0365","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.drugpo.2015.07.010_bib0370","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.drugpo.2012.08.003","article-title":"Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys","volume":"24","author":"Vorobjov","year":"2013","journal-title":"The International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.drugpo.2015.07.010_bib0375","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5694\/mja13.00153","article-title":"Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: the HITS-c study","volume":"201","author":"White","year":"2014","journal-title":"The Medical Journal of Australia"},{"key":"10.1016\/j.drugpo.2015.07.010_bib0380","series-title":"WHO, UNODC, UNAIDS technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users\u20142012 revision","author":"WHO","year":"2012"},{"issue":"7","key":"10.1016\/j.drugpo.2015.07.010_bib0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103345","article-title":"Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention","volume":"9","author":"Wiessing","year":"2014","journal-title":"Plos One"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591500211X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591500211X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T05:51:13Z","timestamp":1717998673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095539591500211X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S095539591500211X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.07.010","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining populations and injecting parameters among people who inject drugs: Implications for the assessment of hepatitis C treatment programs","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}